SSA
OACCW

Schonfeld Strategic Advisors’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Schonfeld Strategic Advisors’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.8K Sell
51,630
-2,106
-4% -$1.65K ﹤0.01% 2007
2025
Q4 		$44.3K Sell
53,736
-5,184
-9% -$4.33K ﹤0.01% 1887
2025
Q3 		$44.2K Sell
58,920
-30,534
-34% -$24.7K ﹤0.01% 2071
2025
Q2 		$78.3K Buy
89,454
+66,243
+285% +$51.1K ﹤0.01% 1856
2025
Q1 		$17.4K Buy
+23,211
New +$17.6K ﹤0.01% 2109

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Schonfeld Strategic Advisors's OACCW Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 3.9% in Q1 2026, selling an estimated $1.65K and leaving 51,630 shares worth $36.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Schonfeld Strategic Advisors first reported a position in OACCW in Q1 2025 and has held it in 5 quarters since. The position peaked at $78.3K in Q2 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Schonfeld Strategic Advisors held 51,630 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $36.8K as of Q1 2026.
  • Schonfeld Strategic Advisors sold 2,106 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $1.65K.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #2007 holding.
  • Schonfeld Strategic Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 5 quarters since.
  • Schonfeld Strategic Advisors's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $78.3K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.